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Ⅰ．T cell development in the thymus 
 The thymus is the only organ that supports T cell 
development, educates T cells, and produces mature T 
cells［1］. Early T cell progenitor cells in the thymus, 
which come from the bone marrow, do not yet have 
any features of T cells; they neither express CD4/CD8 
coreceptors （this is why these cells are named double-
negative ［DN］ cells） nor T cell antigen receptors 
（TCRs） on their surface. DN cells first rearrange their 
TCRβ chain and form preTCRs together with their 
preTα chain, and the cells that successfully form 
preTCRs go through the process called β-selection. 
β-selection induces massive proliferation, and 
eventually the cells become CD4＋CD8＋ double-
positive （DP） cells. DP cells rearrange their TCRα 
chain and eventually express the complete form of 
TCRαβ on their cell surface for the first time during 
their development. TCR rearrangement, the process 
discovered by Nobel laureate Dr. Susumu Tonegawa, 
theoretically creates a broad TCR repertoire （nearly 
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Abstract
The thymus is the only organ that produces T cells where immature thymocytes are properly 
educated and make the correct decision to become appropriate lineage T cells such as CD4+ or CD8+ T 
cells. This process is referred to as ‘lineage choice’. Failure in T cell development and/or lineage choice 
is a direct cause of severe immunodeficiency and/or severe autoimmune disorders. Thus, it is extremely 
important to understand the molecular mechanisms of thymocyte development and lineage choice and 
many immunologists have studied this issue intensively.  
A diverse TCR repertoire （nearly 1018） is generated by TCR gene rearrangement in immature 
thymocytes. It contains autoreactive T cells as well as useless T cells that cannot recognize self-
MHC molecules. These useless T cells are negatively selected （i.e. clonal deletion）, and only cells that 
moderately recognize self-MHC molecules are positively selected. These processes are termed negative 
and positive selection. Positively selected cells further differentiate into either CD4T cells or CD8T 
cells, depending on their specificity to MHC-II or MHC-I respectively. How can the lineage choice of 
T cells, which have a huge TCR repertoire, be properly determined during their development? In this 
review, I will update the recent understanding of the molecular mechanisms underlying the CD4/CD8 
lineage choices in the thymus and explain the mechanisms of error-free MHC-I-dependent CD8 T cell 
development.  
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1018）. Each DP cell expresses different TCRs with 
specificity to different antigens. Importantly, DP cells 
that express the complete form of TCRαβ undergo 
a further developmental process, depending on their 
specificity to the self-antigens presented by the MHC 
class I （MHC-I） or MHC class II （MHC-II） complexes 
（self-MHCs）, which are expressed by the thymus［1］
（Fig. 1）. For instance, DP cells that have a TCR with 
a strong affinity to self-MHCs undergo clonal deletion 
by a process called ‘negative selection’; whereas, DP 
cells that have a TCR with little or no affinity to self-
MHCs undergo cell death by a process called ‘death 
by neglect’. Only DP cells that have a TCR with 
moderate affinity to self-MHCs are positively selected 
and proceed to the next developmental step （Fig. 1）. 
Positively selected DP cells eventually become either 
CD4T or CD8 T cells, depending on the specificity of 
their TCR to the MHC molecule. In this process, called 
‘CD4/CD8 lineage choice’, DP cells that express TCRs 
that recognize the self-MHC-I molecule become CD8T 
cells, while DP cells that express TCRs that recognize 
self-MHC-II become CD4 T cells.  
 Considering the fact that DP cells have a huge 
TCR repertoire and that each DP cell has a chance 
to interact with ‘various’ self-antigens presented by 
thymic epithelial cells （TECs）, the interaction between 
TCRs and self-MHCs must create numerous “analog” 
responses. However, surprisingly, these analog responses 
result in a “unique” lineage choice with almost no errors 
（Fig. 1）. This fact suggests that a strict mechanism 
must exist to allow for an “error-free” proper lineage 
choice. A recent study showed how each DP thymocyte 
expressing different MHC-I-restricted TCRs properly 
differentiated into CD8 T cells［2］. This mechanism will 
be explained later in this review.
Ⅱ． The kinetic signaling model and 
CD4/CD8 lineage choice
 Many immunologists have extensively studied the 
mechanisms of the CD4/CD8 lineage choice in the 
thymus, and many models have been proposed and 
discussed［3-5］. After decades of intense debate, “the 
kinetic signaling model” proposed by the Alfred Singer 
Laboratory （NCI/NIH） is widely accepted as the 
mechanism of CD4/CD8 lineage choice［4］. We herein 
describe the kinetic signaling model （Fig. 2）, and then 
introduce the recent studies that further advance the 
knowledge about the CD4/CD8 lineage choice. 
 DP thymocytes that express the complete form of 
TCR start interacting with TECs that express various 
self-antigens presented by either MHC-I or MHC-II 
molecules. The successful interaction between TCRs and 
self-MHCs provides TCR signaling, which initiates the 
positive selection process. Positively selected cells first 
terminate CD8 gene transcription, regardless of their 
TCR specificity to either MHC, and cells become CD4＋
CD8low （Cd4＋Cd8－） intermediate （IM） cells. Since the 
MHC-I TCR signal is dependent on the CD8 coreceptor, 
the loss of the surface CD8 expression results in the 
cessation of TCR signaling. The cessation of TCR 
signaling allows IM cells to respond to cytokines such 
as IL-7［6,7］, which induces the expression of Runx3d, 
dictating the CD8 lineage fate. In contrast, the loss of the 
surface CD8 expression does not interfere with MHC-
II-dependent TCR signaling, since the MHC-II TCR 
signal is independent of the CD8 expression; thus, the 
TCR signaling of MHC-II-selected cells is continuous. 
Persistent TCR signaling induces the expression of 
Thpok, which promotes CD4 T cell development （Fig. 
2）. In summary, the kinetic signaling model suggests 
that the ‘duration’ of TCR signaling determines the CD4/
Fig. 1　T cell development in the thymus
　Upon TCR gene rearrangement, a broad TCR repertoire 
（nearly 1018） is created. Each DP cell expresses a unique 
TCR, and undergoes a selection process to determine its 
specificity to self-antigens presented by either MHC-I or 
MHC-II molecules that are mainly expressed on thymic 
epithelial cells. The reactivity of each TCR to self-MHCs 
determines the lineage fate.  
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CD8 lineage choice. A long duration of TCR signaling 
induces the expression of Thpok, promoting CD4 helper 
lineage cells; whereas, a short duration of TCR signaling 
results in the induction of IL-7-dependent Runx3d, 
promoting CD8 cytotoxic lineage cells （Fig. 2）. 
Ⅲ．MHC-I-dependent positive selection
 Considering the fact that there is a broad TCR 
repertoire and that there are TECs present various 
types of self-antigens, the affinity of the interactions 
between TCRs and self-MHCs in each cell must be very 
different and these differences are likely to promote 
different durations of TCR signaling. Nevertheless, 
all MHC-II-selected cells become CD4T cells and all 
MHC-I selected cells become CD8 T cells, which may 
contradict the kinetic signaling model that suggests that 
the ‘duration’ of TCR signaling determines the CD4/
CD8 lineage choice. How could the lineage choice be 
well organized［2,4］.?
 Let us look at the details of the process of MHC-I 
positive selection （Fig. 3）. MHC-I-dependent CD8 T 
cells develop in two steps. In the first step, DP cells are 
positively selected and become CD4＋CD8low IM cells; 
this step is referred to as “phase 1”. In the second step, 
IM cells become CD8T cells; this step is referred to as 
“phase 2”. Phase 1 cells are “lineage-undefined” cells; 
whereas, Phase 2 cells are Runx3d expressing “CD8 
lineage-defined” cells （Fig. 3）.  
 To examine the impact of different TCR affinities 
against self-MHC-I for CD8 T cell development, 
we utilized two different TCRs: HY-TCR （female）, 
which is known to have low affinity to the self-MHC-I 
molecule; and OTI-TCR, which is known to have high 
affinity to the self-MHC-I molecule. To measure the 
amount of time in each phase, we utilized RAG2GFP Tg 
mice［2,8］. We first found that the Phase 1 duration is 
controlled by TCR signaling driven by positive selection. 
In fact, low-affinity HY-TCR-dependent signaling was 
Fig. 2　The kinetic signaling model
　TCR-signaled positively selected cells first terminate 
CD8 gene transcription, and become CD4＋CD8low （Cd4＋
Cd8 －） intermediate （IM） cells. Since MHC-I TCR 
signaling is dependent on the CD8 coreceptor, the loss 
of the surface CD8 expression results in the cessation of 
TCR signaling, which allows IM cells to respond to IL-7, 
inducing the expression of Runx3d, which dictates the CD8 
lineage fate. In contrast, the TCR signaling of MHC-II-
selected cells is continuous, since MHC-II TCR signaling 
is independent of the expression of CD8. Persistent TCR 
signaling induces the expression of Thpok, which results 
in CD4 T cell development. The kinetic signaling model 
suggests that the duration of TCR signaling determines the 
CD4/CD8 lineage choice.  
Fig. 3　The basis of MHC-I-dependent positive selection
　MHC-I-dependent CD8 T cell development has two 
steps. In the first step, positively selected DP cells become 
CD4＋CD8low IM cells; this is referred to as “phase 1”. 
In the second step, IM cells become CD8T cells by 
responding cytokines such as IL-7; this is referred to as 
“phase 2”. Phase 1 cells are “lineage-undefined” cells; 
whereas Phase 2 cells are Runx3-expressing “CD8 lineage-
defined” cells. Phase 1 is controlled by TCR signaling; 
thus, DP cells that express low-affinity TCRs （e.g. HY-
TCR） have a short phase 1 but long phase 2, while DP 
cells that express high-affinity TCRs （e.g. OTI-TCR） have 
long phase 1 but short phase 2. A longer phase 1 duration 
increases the cytokine responsiveness of IM cells so that 
the cytokine-driven duration of Phase 2 becomes shorter. 
As a result, the total time for positive selection is almost 
constant. Error-free MHC-I positive selection requires 
phase 1 to end within 53 hours. 
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found to cease quickly （after approximately 19 hours） 
because the interaction between the low-affinity TCR 
and the MHC-I molecule is highly dependent on the 
CD8 molecule; thus, a relatively small decrease in the 
surface CD8 expression （IM1 in Fig. 3） results in the 
disruption of the TCR-MHC complex. In contrast, the 
duration of high-affinity OTI-TCR-dependent signaling 
is long （approximately 53 hours）; it lasts until the 
surface CD8 expression decreases to a level that is 
low enough to disrupt TCR signaling （IM2 in Fig. 3）. 
Interestingly, however, we found that low-affinity HY-
TCR requires a long phase 2 period to become CD8 
T cells （approximately 79 hours）; whereas, high-
affinity OTI-TCR has a short phase 2 （approximately 
33 hours）. As a result, the total time for positive 
selection is similar for both T cells［2］. How can this 
phenomenon be explained? Delicate experiments 
revealed the crucial relationship between phases 1 and 
2, in which the duration of phase 1 determines the 
cytokine responsiveness of IM cells so that the duration 
of phase 2 is influenced by the duration of phase 1. For 
instance, a longer phase 1 duration with high-affinity 
TCRs such as OTI-TCR increases the cytokine （such 
as IL-7） responsiveness of IM cells so that the duration 
of IL-7-driven phase 2 becomes shorter. In contrast, the 
short duration of phase 1 with low-affinity TCRs such 
as HY TCR is not sufficient to allow for a response to 
IL-7; thus, phase 2 takes longer （Fig. 3）. In this way, 
immature developing T cells that express various TCRs, 
each of which have a different affinity to self-MHC-I, 
can efficiently differentiate into mature CD8 T cells 
within a certain time［2］. 
 The fact that the CD4/CD8 lineage choice is 
determined by the duration of TCR signaling made 
us wonder whether an extremely-high-affinity MHC-
I-restricted TCR would result in them erroneously 
becoming CD4 T cells. To address this question, we 
utilized CD8.4 knock-in mice, in which the CD8.4 gene 
is knocked into the CD8 α gene locus［9］. The CD8.4 
molecule is a chimeric molecule that consists of the 
extracellular domain of CD8α gene and the intracellular 
domain of the CD4 gene; thus, CD8.4-dependent 
MHC-I signaling becomes stronger than CD8-dependent 
MHC-I signaling, although the interaction between 
CD8.4-MHC-I and CD8-MHC-I is the same［9］. We 
introduced the CD8.4 allele into MHC-I restricted 
TCR Tg mice, and found that low-affinity TCRs such 
as HY-TCR or F5-TCR with the CD8.4 allele result in 
more positively selected cells; however, the erroneous 
development of CD4 T cells was not observed［2,9］. 
In contrast, high-affinity TCRs such as OTI-TCR with 
the CD8.4 allele resulted in lineage errors, in which 
some OTI T cells with the CD8.4 molecule developed 
into CD4 T cells, even though OTI TCR is an MHC-I-
restricted TCR. Accordingly, we revealed that “error-
free MHC-I positive selection requires phase 1 to end 
within 53 hours”［2］. In general, the cytosolic tail of the 
CD8 molecule produces weaker signals than the CD4 
molecule; this aspect, which is designed by Mother 
Nature, must be important for error-free CD8 T cell 
development. 
Ⅳ．Concluding remarks and Future perspectives
 Studies in recent decades have revealed a great deal 
of information about the molecular mechanism of T cell 
development in the thymus; however, new knowledge 
always open the door to new questions. The thymus 
produces all types of T cells, not only regular CD4＋ and 
CD8＋ T cells, but also innate T lymphocytes, such as 
natural killer T cells and mucosal-associated invariant 
T cells. These innate lymphocytes have regulatory 
functions and contribute to immune homeostasis and 
immune responses; however, the molecular mechanism 
of innate T lymphocyte development is still not fully 
understood. It is important to understand how these 
T cells recognize self-antigens （or nonself-antigens） 
in the thymus and how that recognition determines 
their lineage choice. The elucidation of the detailed 
mechanisms of thymocyte development is important for 
understanding the body’s immune system. 
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